BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

2.130

-0.170 (-7.39%)

At close: Feb 21, 2025, 4:00 PM

2.260

+0.130 (6.10%)

After-hours: Feb 21, 2025, 6:54 PM EST

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $6.61 million as of February 21, 2025. Its market cap has decreased by -94.54% in one year.

Market Cap

6.61M

Enterprise Value

71.19M

1-Year Change

-94.54%

Ranking

#5235

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $6.61M, a decrease of -96.17%. That is a compound annual growth rate of -37.40%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	6.61M	-64.40%
Dec 31, 2024	18.56M	-78.51%
Dec 29, 2023	86.35M	-85.65%
Dec 30, 2022	601.94M	5.82%
Dec 31, 2021	568.84M	-49.47%
Dec 31, 2020	1.13B	327.27%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings